Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease

Clinical trial NCT00088673 · UNKNOWN

Trial details

NCT number: NCT00088673
Sponsor: Bellus Health Inc. - a GSK company
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2004-06-01
Enrollment: 950

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.